BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4186456)

  • 1. Fatal systemic measles in a child receiving cyclophosphamide for nephrotic syndrome.
    Meadow SR; Weller RO; Archibald RW
    Lancet; 1969 Oct; 2(7626):876-8. PubMed ID: 4186456
    [No Abstract]   [Full Text] [Related]  

  • 2. Measles pneumonia and the nature of the inclusion-bearing giant cells: a light- and electron-microscope study.
    Archibald RW; Weller RO; Meadow SR
    J Pathol; 1971 Jan; 103(1):27-34. PubMed ID: 5566423
    [No Abstract]   [Full Text] [Related]  

  • 3. The congenital nephrotic syndrome.
    Wiggelinkhuizen J; Kaschula RO; McDonald R; Uys CJ
    S Afr Med J; 1972 May; 46(22):684-9. PubMed ID: 5057327
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute lymphoblastic leukaemia after treatment of nephrotic syndrome with immunosuppressive drugs.
    Kuis W; de Kraker J; Kuijten RH; Donckerwolcke RA; Voûte PA
    Helv Paediatr Acta; 1976 Jun; 31(1):91-5. PubMed ID: 1065623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotic syndrome of childhood: malaria therapy reconsidered.
    Barratt TM
    Arch Dis Child; 1979 Nov; 54(11):825-30. PubMed ID: 316687
    [No Abstract]   [Full Text] [Related]  

  • 6. Idiopathic nephrotic syndrome of childhood: cyclophosphamide induced conversion from steroid refractory to highly steroid sensitive disease.
    Bergstrand A; Bollgren I; Samuelsson A; Törnroth T; Wasserman J; Winberg J
    Clin Nephrol; 1973; 1(5):302-6. PubMed ID: 4129067
    [No Abstract]   [Full Text] [Related]  

  • 7. Histopathological and immunological studies in spontaneous remission of nephrotic syndrome after intercurrent measles infection.
    Lin CY; Hsu HC
    Nephron; 1986; 42(2):110-5. PubMed ID: 3484807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome of childhood.
    Barratt TM; Bercowsky A; Osofsky SG; Soothill JF
    Lancet; 1975 Jan; 1(7898):55-8. PubMed ID: 46019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential protein clearances in Indian children with the nephrotic syndrome.
    Chandra RK; Manchanda SS; Srivastava RN; Soothill JF
    Arch Dis Child; 1970 Aug; 45(242):491-5. PubMed ID: 4097001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophosphamide in the treatment of the nephrotic syndrome in childhood.
    Spitzer A
    Pediatrics; 1972 Sep; 50(3):358-60. PubMed ID: 5056408
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclophosphamide pulse therapy in relapsing nephrotic syndrome.
    Wardle EN
    Nephron; 1991; 58(3):377. PubMed ID: 1896110
    [No Abstract]   [Full Text] [Related]  

  • 12. Current management of the nephrotic syndrome in childhood with emphasis on the role of cyclophosphamide.
    Kelsch RC; Oliver WJ
    Mich Med; 1972 Dec; 71(35):999-1003. PubMed ID: 4636891
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclophosphamide in the nephrotic syndrome of childhood: its use in two groups of patients defined by clinical, light microscopic and immunopathologic findings.
    Drummond KN; Hillman DA; Marchessault JH; Feldman W
    Can Med Assoc J; 1968 Mar; 98(11):524-31. PubMed ID: 5643296
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide.
    Cameron JS; Chantler C; Ogg CS; White RH
    Br Med J; 1974 Oct; 4(5935):7-11. PubMed ID: 4425844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide therapy in adults with minimal-change nephrotic syndrome.
    Uldall PR; Feest TG; Morley AR; Tomlinson BE; Kerr DN
    Lancet; 1972 Jun; 1(7763):1250-3. PubMed ID: 4113514
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclophosphamide therapy in idiopathic nephrotic syndrome--a new treatment.
    Dundon S; Carroll R; Dunleavy M; Raftery J
    J Ir Med Assoc; 1971 May; 64(411):243-6. PubMed ID: 5578246
    [No Abstract]   [Full Text] [Related]  

  • 17. A controlled trial of cyclophosphamide and azathioprine in Nigerian children with the nephrotic syndrome and poorly selective proteinuria.
    Adeniyi A; Hendrickse RG; Soothill JF
    Arch Dis Child; 1979 Mar; 54(3):204-7. PubMed ID: 373645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive measles encephalopathy.
    Pedersen FK; Schiøtz PO; Valerius NH; Hertz H
    Acta Paediatr Scand; 1978 Jan; 67(1):109-12. PubMed ID: 626062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
    Gulati A; Sinha A; Gupta A; Kanitkar M; Sreenivas V; Sharma J; Mantan M; Agarwal I; Dinda AK; Hari P; Bagga A
    Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term effects of cyclophosphamide therapy in treatment of the "primary" nephrotic syndrome of childhood].
    Lama G
    Pediatria (Napoli); 1976 Jun; 84(2):320-30. PubMed ID: 798171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.